Huron Consulting Group Inc. (NASDAQ:HURN – Get Free Report) Director James H. Roth sold 2,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $123.70, for a total value of $247,400.00. Following the completion of the sale, the director now owns 52,825 shares in the company, valued at $6,534,452.50. This trade represents a 3.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Huron Consulting Group Stock Performance
Shares of NASDAQ HURN opened at $123.11 on Monday. The stock’s 50-day moving average is $115.63 and its 200 day moving average is $107.09. The stock has a market cap of $2.18 billion, a price-to-earnings ratio of 26.76 and a beta of 0.60. Huron Consulting Group Inc. has a 1-year low of $84.26 and a 1-year high of $131.06. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82.
Huron Consulting Group (NASDAQ:HURN – Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The business services provider reported $1.68 EPS for the quarter, topping the consensus estimate of $1.57 by $0.11. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The firm had revenue of $370.00 million for the quarter, compared to the consensus estimate of $377.63 million. During the same period last year, the firm posted $1.39 earnings per share. The business’s revenue was up 3.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.
Institutional Trading of Huron Consulting Group
Analyst Ratings Changes
Several analysts have weighed in on the company. Barrington Research raised their price target on Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a report on Monday, November 4th. StockNews.com raised shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Thursday, October 31st. Finally, Benchmark reissued a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a research note on Wednesday, October 30th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $133.00.
Check Out Our Latest Analysis on HURN
Huron Consulting Group Company Profile
Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.
Further Reading
- Five stocks we like better than Huron Consulting Group
- How to Invest in Biotech Stocks
- Guidewire Software Provides Long-Awaited Buying Opportunity
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Fast-Growing Companies That Are Still Undervalued
Receive News & Ratings for Huron Consulting Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huron Consulting Group and related companies with MarketBeat.com's FREE daily email newsletter.